Jeff Flick is an accomplished inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biomedical research, particularly in the area of predicting preterm birth. With a total of 3 patents to his name, Flick's work is paving the way for advancements in maternal health.

Latest Patents

Flick's latest patents focus on biomarker pairs for predicting preterm birth. The disclosures provide pairs of isolated biomarkers selected from a specific group, including IBP4/SHBG, IBP4/PSG3, and others. These biomarkers exhibit a change in reversal value between pregnant females at risk for preterm birth and term controls. Additionally, the patents outline a method for determining the probability of preterm birth in a pregnant female by measuring reversal values in biological samples.

Career Highlights

Jeff Flick is currently associated with Sera Prognostics, Inc., where he continues to innovate in the field of prenatal health. His work is instrumental in developing predictive tools that can significantly impact maternal and fetal health outcomes.

Collaborations

Flick collaborates with notable colleagues, including John Jay Boniface and Andrew Gassman, who contribute to the research and development efforts at Sera Prognostics, Inc.

Conclusion

Jeff Flick's innovative work in biomarker research is crucial for improving the prediction of preterm birth, showcasing his dedication to advancing maternal health. His contributions are expected to have a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.